ArticleJournal of Cancer2021

Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1.

Xizi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.